Purchases and Sales Made in Q2 2023 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q2 2023. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
3.69K+ 9.19% |
$9.27K - $13.7K
|
43.9K
$47.4K
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2.31K+ 3204.17% |
$5.79K - $8.56K
|
2.38K
$2.57K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
2K+ 3.66% |
$5.02K - $7.42K
|
56.7K
$61.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Srs Capital Advisors, Inc.
Denver, CO |
BUY
|
- |
290New |
$728 - $1.08K
|
290
$313
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-38- 0.3% |
$95.4 - $141
|
12.7K
$13.7K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.81K- 16.96% |
$4.55K - $6.73K
|
8.88K
$9.59K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group Ltd.
Dublin, L2 |
SELL
|
- |
-2.78K- 15.53% |
$6.97K - $10.3K
|
15.1K
$16.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-7.57K- 40.13% |
$19K - $28.1K
|
11.3K
$12.2K
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-7.57K- 40.13% |
$19K - $28.1K
|
11.3K
$12.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-10.8K- 21.93% |
$27.2K - $40.2K
|
38.6K
$41.7K
|
|
|
Aug 09, 2023
Q2 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-12.4K- 91.85% |
$31.1K - $46K
|
1.1K
$1.19K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-13.6K- 43.38% |
$34.2K - $50.6K
|
17.8K
$19.2K
|